Total Funding
22
67
Total FundingSeed raised
Growth Score 22 in past quarter
-1 pts
Heat Score 67 in past quarter
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
186237
Moirai Biodesign is developing RNA technologies for diagnostics and therapeutics.
- Salva Duran-Nebreda: Founder & VP of Research
- Nuria Conde: Founder and CSO
About the Company
Moirai Biodesign is a biotechnology company that develops RNA-based technologies for cancer-related diagnostics and therapeutics.
The company develops non-invasive tests for the in-situ diagnosis of different types of cancer from a patient’s blood, in-vivo diagnosis systems for surgical assistance and patient monitoring, and therapeutical drugs
for the treatment of cancer.
Moirai Biodesign was founded in 2016 and is based in Barcelona, Spain.
